Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
Articles that Changed Our Practice - Part 2
Articles that Changed Our Practice - Part 2
Articles that Changed Our Practice - Part 2
Monday 25th March 2024
Explore five pivotal studies that have reshaped addiction medicine practice with Dr. Sonia del Tredici and Dr. John Keenan.
43 minutes
Informative
Engaging
Supportive
Educational
Hopeful
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
55 (View all)
Do you want to link to this podcast?
Get the buttons here!Game-Changing Articles in Addiction Medicine: Part 2
Episode Overview
- Higher doses of buprenorphine can improve retention in treatment.
- Combining Varenicline with counselling boosts vaping cessation success.
- Patient-centred models enhance hepatitis C treatment outcomes.
- Co-prescribing opioid agonists with other meds increases overdose risk.
- Medication-assisted treatment reduces mortality in opioid use disorder.
It's like in terms of mortality, harm reduction, it's the meds right.
In this episode of Addiction Medicine Journal Club, Dr. Sonia del Tredici and Dr. John Keenan continue their engaging discussion on the articles that have significantly impacted their addiction medicine practice. If you’ve ever wondered how cutting-edge research translates into real-world treatment, this episode is a must-listen. They dive into five pivotal studies, sharing both professional insights and personal experiences from their own practices.
You'll hear about a patient struggling with opioid use disorder and the surprising benefits of higher doses of buprenorphine, as highlighted in a JAMA Network Open study. Dr. del Tredici and Dr. Keenan also explore a trial on Varenicline and counselling for vaping cessation, offering new strategies for those battling nicotine addiction. Another key topic is the innovative patient-centred models for hepatitis C treatment among people who inject drugs, which has inspired changes in their own treatment protocols.
They further discuss the risks associated with co-prescribing opioid agonists and other medications, drawing from a comprehensive study on non-fatal overdose risks. Finally, they tackle the controversial topic of inpatient treatment versus medication-assisted treatment for opioid use disorder, supported by data from Connecticut’s expert panel review. Throughout the episode, the hosts maintain a light-hearted yet deeply informative tone, making complex medical research accessible and relevant. Don’t miss out on these transformative insights that could change how you approach addiction treatment.